ERYFLUID 40mg / ml skin solution medication leaflet

D10AF02 erythromycin • Dermatologicals | Anti-acne preparations for topical use | Antiinfectives for treatment of acne

Erythromycin is an antibiotic from the macrolide class, used to treat infections caused by susceptible bacteria. It works by inhibiting bacterial protein synthesis, which stops the growth and multiplication of bacteria. It is effective against a wide range of gram-positive and gram-negative bacteria.

Erythromycin is indicated for the treatment of respiratory infections (such as bronchitis, pneumonia), skin and soft tissue infections, ear infections, eye infections, and certain sexually transmitted diseases, such as syphilis or chlamydia. It can also be used as an alternative to penicillin for patients allergic to it.

The medication is available in the form of tablets, oral suspensions, injectable solutions, or topical ointments. Common side effects include nausea, vomiting, diarrhea, abdominal pain, and, rarely, allergic reactions or liver disorders. It is important to take erythromycin as prescribed by a healthcare provider, and patients should avoid concurrent use with certain medications that may interact with it, such as statins or anticoagulants.

General data about ERYFLUID 40mg / ml

Substance: erythromycin

Date of last drug list: 01-03-2022

Commercial code: W02981002

Concentration: 40mg / ml

Pharmaceutical form: skin solution

Packing volume: 100ml

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PIERRE FABRE MEDICAMENT PRODUCTION - FRANTA

Holder: PIERRE FABRE DERMATOLOGIE - FRANTA

Number: 6282/2006/02

Shelf life: 2 years

Pharmaceutical forms available for erythromycin

Concentrations available for erythromycin

125mg/5ml, 200mg, 200mg/5ml, 40mg/ml